Clinical Trials
142 trialsCZECH-PSMA
General University Hospital, Prague
AWARE
Rigshospitalet, Denmark
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Fox Chase Cancer Center
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
National Institutes of Health Clinical Center (CC)
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
Peking University First Hospital
OvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
ProsTIC Registry of Men Treated With PSMA Theranostics
Peter MacCallum Cancer Centre, Australia
INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Trakya University
PARADIGM
University College, London
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
CISTO
University of Washington
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
DAROL
Bayer
CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study
Jonsson Comprehensive Cancer Center
ITHORinVHL
IRCCS San Raffaele
ArtemisPRO
Janssen-Cilag Ltd.
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older
Memorial Sloan Kettering Cancer Center
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Memorial Sloan Kettering Cancer Center
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
CABOCARE
Ipsen
REPLICA
Ipsen
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
M.D. Anderson Cancer Center
ELEPHAS-02
Elephas
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc.
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
Mayo Clinic
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Mayo Clinic
DADOX
Bayer
RE-ENGAGE
Bayer
BladMetrix
Oslo University Hospital
OPTYX
Sumitomo Pharma America, Inc.
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Memorial Sloan Kettering Cancer Center
ROAD
Bayer
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
University of Southern California
QoLProstateMQ
University Hospital Center of Martinique
PCT
Abramson Cancer Center at Penn Medicine
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Consorci Sanitari de Terrassa
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population
Hospital Moinhos de Vento
SPECT/CT for the Characterization of Renal Masses
Jonsson Comprehensive Cancer Center
A Study of miRNA 371 in Patients With Germ Cell Tumors
SWOG Cancer Research Network
Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
University of Pennsylvania
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Memorial Sloan Kettering Cancer Center
COMBINE-P
Heinrich-Heine University, Duesseldorf
VANDAAM
H. Lee Moffitt Cancer Center and Research Institute
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
PRINToUT
NHS Lothian
ODYSSEY RCC
Duke University
OU-SCC-PROBX
University of Oklahoma
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma